CN101778938B - 降低核酸酶活性 - Google Patents
降低核酸酶活性 Download PDFInfo
- Publication number
- CN101778938B CN101778938B CN200880103327.4A CN200880103327A CN101778938B CN 101778938 B CN101778938 B CN 101778938B CN 200880103327 A CN200880103327 A CN 200880103327A CN 101778938 B CN101778938 B CN 101778938B
- Authority
- CN
- China
- Prior art keywords
- subtilisin
- activity
- initial value
- minutes
- solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 101710163270 Nuclease Proteins 0.000 title claims abstract description 27
- 108090000787 Subtilisin Proteins 0.000 claims abstract description 97
- 230000000694 effects Effects 0.000 claims abstract description 59
- 238000000034 method Methods 0.000 claims abstract description 29
- 239000007788 liquid Substances 0.000 claims description 19
- 230000008569 process Effects 0.000 claims description 15
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 11
- 238000011534 incubation Methods 0.000 claims description 11
- 241000193830 Bacillus <bacterium> Species 0.000 claims description 8
- 108010056079 Subtilisins Proteins 0.000 claims description 7
- 102000005158 Subtilisins Human genes 0.000 claims description 7
- 238000000108 ultra-filtration Methods 0.000 claims description 7
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 6
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims description 4
- 108010020132 microbial serine proteinases Proteins 0.000 claims description 3
- GUBGYTABKSRVRQ-CUHNMECISA-N D-Cellobiose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-CUHNMECISA-N 0.000 claims description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims description 2
- HEBKCHPVOIAQTA-QWWZWVQMSA-N D-arabinitol Chemical compound OC[C@@H](O)C(O)[C@H](O)CO HEBKCHPVOIAQTA-QWWZWVQMSA-N 0.000 claims description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims description 2
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 claims description 2
- 229930195725 Mannitol Natural products 0.000 claims description 2
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims description 2
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 claims description 2
- FBPFZTCFMRRESA-GUCUJZIJSA-N galactitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-GUCUJZIJSA-N 0.000 claims description 2
- 239000000594 mannitol Substances 0.000 claims description 2
- 235000010355 mannitol Nutrition 0.000 claims description 2
- 239000000843 powder Substances 0.000 claims description 2
- 239000000600 sorbitol Substances 0.000 claims description 2
- 239000000811 xylitol Substances 0.000 claims description 2
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims description 2
- 235000010447 xylitol Nutrition 0.000 claims description 2
- 229960002675 xylitol Drugs 0.000 claims description 2
- 102000006382 Ribonucleases Human genes 0.000 claims 1
- 108010083644 Ribonucleases Proteins 0.000 claims 1
- 238000000855 fermentation Methods 0.000 abstract description 8
- 230000004151 fermentation Effects 0.000 abstract description 8
- 229920005862 polyol Polymers 0.000 abstract 1
- 150000003077 polyols Chemical class 0.000 abstract 1
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 12
- 108091005804 Peptidases Proteins 0.000 description 11
- 102000035195 Peptidases Human genes 0.000 description 11
- 239000000243 solution Substances 0.000 description 11
- 238000013016 damping Methods 0.000 description 9
- 239000012530 fluid Substances 0.000 description 9
- 238000002156 mixing Methods 0.000 description 9
- 239000000758 substrate Substances 0.000 description 8
- 238000012360 testing method Methods 0.000 description 8
- 102000004190 Enzymes Human genes 0.000 description 7
- 108090000790 Enzymes Proteins 0.000 description 7
- 150000001875 compounds Chemical class 0.000 description 7
- 229940088598 enzyme Drugs 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 239000004365 Protease Substances 0.000 description 5
- 230000009849 deactivation Effects 0.000 description 5
- 230000002779 inactivation Effects 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 244000005700 microbiome Species 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 241001328122 Bacillus clausii Species 0.000 description 3
- 241000193422 Bacillus lentus Species 0.000 description 3
- 241000194108 Bacillus licheniformis Species 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
- 102000016911 Deoxyribonucleases Human genes 0.000 description 3
- 108010053770 Deoxyribonucleases Proteins 0.000 description 3
- 230000003197 catalytic effect Effects 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 239000012634 fragment Substances 0.000 description 3
- 108020004707 nucleic acids Proteins 0.000 description 3
- 102000039446 nucleic acids Human genes 0.000 description 3
- 150000007523 nucleic acids Chemical class 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 2
- 241000193752 Bacillus circulans Species 0.000 description 2
- 241000193749 Bacillus coagulans Species 0.000 description 2
- 241000194107 Bacillus megaterium Species 0.000 description 2
- 241000194103 Bacillus pumilus Species 0.000 description 2
- 244000063299 Bacillus subtilis Species 0.000 description 2
- 241000193388 Bacillus thuringiensis Species 0.000 description 2
- 241000193764 Brevibacillus brevis Species 0.000 description 2
- 241000579835 Merops Species 0.000 description 2
- 241000194109 Paenibacillus lautus Species 0.000 description 2
- 229920004890 Triton X-100 Polymers 0.000 description 2
- 239000013504 Triton X-100 Substances 0.000 description 2
- 229940054340 bacillus coagulans Drugs 0.000 description 2
- 229940097012 bacillus thuringiensis Drugs 0.000 description 2
- 238000007865 diluting Methods 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 239000006052 feed supplement Substances 0.000 description 2
- 238000005189 flocculation Methods 0.000 description 2
- 230000016615 flocculation Effects 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000002203 pretreatment Methods 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000012224 working solution Substances 0.000 description 2
- RNAMYOYQYRYFQY-UHFFFAOYSA-N 2-(4,4-difluoropiperidin-1-yl)-6-methoxy-n-(1-propan-2-ylpiperidin-4-yl)-7-(3-pyrrolidin-1-ylpropoxy)quinazolin-4-amine Chemical compound N1=C(N2CCC(F)(F)CC2)N=C2C=C(OCCCN3CCCC3)C(OC)=CC2=C1NC1CCN(C(C)C)CC1 RNAMYOYQYRYFQY-UHFFFAOYSA-N 0.000 description 1
- UXFQFBNBSPQBJW-UHFFFAOYSA-N 2-amino-2-methylpropane-1,3-diol Chemical compound OCC(N)(C)CO UXFQFBNBSPQBJW-UHFFFAOYSA-N 0.000 description 1
- 241000193744 Bacillus amyloliquefaciens Species 0.000 description 1
- 241000006382 Bacillus halodurans Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 239000002028 Biomass Substances 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 125000003275 alpha amino acid group Chemical group 0.000 description 1
- 102000004139 alpha-Amylases Human genes 0.000 description 1
- 108090000637 alpha-Amylases Proteins 0.000 description 1
- 229940024171 alpha-amylase Drugs 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 238000010923 batch production Methods 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 230000001351 cycling effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 108010003855 mesentericopeptidase Proteins 0.000 description 1
- 238000001471 micro-filtration Methods 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 description 1
- 238000002708 random mutagenesis Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000004064 recycling Methods 0.000 description 1
- 230000008521 reorganization Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000003757 reverse transcription PCR Methods 0.000 description 1
- 108091092562 ribozyme Proteins 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000002741 site-directed mutagenesis Methods 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000007669 thermal treatment Methods 0.000 description 1
- 238000010977 unit operation Methods 0.000 description 1
- 238000009834 vaporization Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/99—Enzyme inactivation by chemical treatment
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/52—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
- C12N9/54—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea bacteria being Bacillus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/96—Stabilising an enzyme by forming an adduct or a composition; Forming enzyme conjugates
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Enzymes And Modification Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP07114613.8 | 2007-08-20 | ||
| EP07114613 | 2007-08-20 | ||
| PCT/EP2008/060855 WO2009024574A1 (en) | 2007-08-20 | 2008-08-19 | Nuclease reduction |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101778938A CN101778938A (zh) | 2010-07-14 |
| CN101778938B true CN101778938B (zh) | 2014-07-02 |
Family
ID=39027651
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN200880103327.4A Active CN101778938B (zh) | 2007-08-20 | 2008-08-19 | 降低核酸酶活性 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US8557553B2 (da) |
| EP (1) | EP2181191B1 (da) |
| CN (1) | CN101778938B (da) |
| AT (1) | ATE498007T1 (da) |
| DE (1) | DE602008004924D1 (da) |
| DK (1) | DK2181191T3 (da) |
| WO (1) | WO2009024574A1 (da) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102011115328A1 (de) | 2011-10-07 | 2013-04-11 | Mtu Friedrichshafen Gmbh | Verfahren zum Überwachen einer Abgasanlage |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3623957A (en) * | 1970-01-21 | 1971-11-30 | Baxter Laboratories Inc | Preparation of microbial alkaline protease by fermentation with bacillus subtilis, variety licheniformis |
| WO1998004730A1 (en) * | 1996-07-29 | 1998-02-05 | Promega Corporation | Methods for isolating nucleic acids using alkaline protease |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4569911A (en) * | 1984-01-19 | 1986-02-11 | Uop Inc. | Method of making aspartic acid and purifying aspartase |
| US5371198A (en) * | 1991-12-16 | 1994-12-06 | Novo Nordisk A/S | Method for protection of proteolysis-susceptible protein during protein production in a fluid medium |
| US5256557A (en) | 1991-12-27 | 1993-10-26 | Solvay Enzymes, Inc. | Purified alkaline protease concentrate and method of preparation |
| US6207437B1 (en) * | 1996-03-11 | 2001-03-27 | Genencor International, Inc. | Crystalline protease and method for producing same |
| US7264932B2 (en) * | 1999-09-24 | 2007-09-04 | Applera Corporation | Nuclease inhibitor cocktail |
| AU2001277957A1 (en) * | 2000-07-22 | 2002-02-05 | Genencor International, Inc. | Stabilization of enzymes |
| US7001724B1 (en) * | 2000-11-28 | 2006-02-21 | Applera Corporation | Compositions, methods, and kits for isolating nucleic acids using surfactants and proteases |
| DK1339837T3 (da) * | 2000-12-07 | 2008-06-09 | Dsm Ip Assets Bv | Prolyl-endoprotease fra Aspergillus Niger |
| US20060188892A1 (en) * | 2005-02-18 | 2006-08-24 | Ambion, Inc. | Enzymatic digestion of tissue |
-
2008
- 2008-08-19 AT AT08787332T patent/ATE498007T1/de not_active IP Right Cessation
- 2008-08-19 US US12/671,973 patent/US8557553B2/en active Active
- 2008-08-19 EP EP08787332A patent/EP2181191B1/en active Active
- 2008-08-19 DE DE602008004924T patent/DE602008004924D1/de active Active
- 2008-08-19 CN CN200880103327.4A patent/CN101778938B/zh active Active
- 2008-08-19 WO PCT/EP2008/060855 patent/WO2009024574A1/en active Application Filing
- 2008-08-19 DK DK08787332.9T patent/DK2181191T3/da active
-
2013
- 2013-09-11 US US14/024,059 patent/US20140011254A1/en not_active Abandoned
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3623957A (en) * | 1970-01-21 | 1971-11-30 | Baxter Laboratories Inc | Preparation of microbial alkaline protease by fermentation with bacillus subtilis, variety licheniformis |
| WO1998004730A1 (en) * | 1996-07-29 | 1998-02-05 | Promega Corporation | Methods for isolating nucleic acids using alkaline protease |
Non-Patent Citations (2)
| Title |
|---|
| finlayson s d,et al.Preparation of a Nuclease-free Alpha Amylase and Its Use in DNA Purification.《BIOTECHNOLOGY TECHNIQUES》.1992,第6卷(第1期),53-54. * |
| 周景祥等.蛋白酶和淀粉酶活性检测方法探讨.《中国饲料》.2001,(第11期),23-25. * |
Also Published As
| Publication number | Publication date |
|---|---|
| DK2181191T3 (da) | 2011-05-23 |
| US20140011254A1 (en) | 2014-01-09 |
| EP2181191B1 (en) | 2011-02-09 |
| WO2009024574A1 (en) | 2009-02-26 |
| US8557553B2 (en) | 2013-10-15 |
| EP2181191A1 (en) | 2010-05-05 |
| DE602008004924D1 (de) | 2011-03-24 |
| US20110229954A1 (en) | 2011-09-22 |
| ATE498007T1 (de) | 2011-02-15 |
| CN101778938A (zh) | 2010-07-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Pant et al. | Production, optimization and partial purification of protease from Bacillus subtilis | |
| Kaur et al. | Enhanced production and characterization of a highly thermostable alkaline protease from Bacillus sp. P-2 | |
| Merheb et al. | Partial characterization of protease from a thermophilic fungus, Thermoascus aurantiacus, and its hydrolytic activity on bovine casein | |
| EP3959326B1 (en) | Industrial fermentation process for microbial cells using a fed-batch pre-culture | |
| Bezawada et al. | Recovery of Bacillus licheniformis alkaline protease from supernatant of fermented wastewater sludge using ultrafiltration and its characterization | |
| Senthilkumar et al. | Amylase production by Bacillus sp. using cassava as substrate | |
| EP1520011A2 (en) | Sterilisation of a fermentation medium comprising hydrolysed n-source | |
| CN114096676A (zh) | 用确定成分培养基和镁补料的芽孢杆菌工业发酵工艺 | |
| CN101918551A (zh) | 草酸脱羧酶的生产中利用的重组表达质粒载体及重组菌、以及重组草酸脱羧酶的生产方法 | |
| Mathew et al. | Production, purification and characterization of a thermostable alkaline serine protease from Bacillus lichniformis NMS-1 | |
| CN101778938B (zh) | 降低核酸酶活性 | |
| US20120122183A1 (en) | Flocculation with divalent salt and phosphate | |
| EP3137483B1 (en) | Method for reducing the dna content of a fermentation broth | |
| EP2742145A1 (en) | Reduction of culture viscosity by manganese addition | |
| Vasantha et al. | Optimization of cultural conditions for the production of an extracellular protease by Pseudomonas species | |
| DK2552934T3 (da) | Krystalmetabolit-indvinding | |
| CN103339251A (zh) | 褐化葡萄糖作为进料基质的用途 | |
| Kaur et al. | Enhancement of alkaline protease production from newly isolated strain Bacillus paramycoides using potato peel and mustard oil cake as substrate. | |
| Shata et al. | Optimization of extraction parameters for keratinase recovery from fermented feather under solid state fermentation by Streptomyces sp. NRC 13S | |
| WO2004003187A2 (en) | Mpg added to fermentation | |
| JP2844350B2 (ja) | 微生物が生産する物質の製造法 | |
| CN101278044A (zh) | 适用于制备重组多肽的突变体细胞 | |
| CN113993878A (zh) | 用二价阳离子从发酵液中回收蛋白的方法 | |
| US20040033567A1 (en) | Hydrolysed N-source | |
| EP3665267A1 (en) | Use of fca control based on ph |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant |